Your browser doesn't support javascript.
loading
Metabotropic Glutamate Receptors Modulate Exocytotic Tau Release and Propagation.
Mazzo, Francesca; Butnaru, Ioana; Grubisha, Olivera; Ficulle, Elena; Sanger, Helen; Fitzgerald, Griffin; Pan, Feng; Pasqui, Francesca; Murray, Tracey; Monn, James; Li, Xia; Hutton, Michael; Bose, Suchira; Schiavo, Giampietro; Sher, Emanuele.
Affiliation
  • Mazzo F; Eli Lilly and Company Ltd, Neuroscience, Bracknell, United Kingdom (F.M., O.G., E.F., H.S., Fr.P., T.M., S.B., E.S.); UK Dementia Research Institute at UCL, University College London, London, United Kingdom (I.B., G.S.); Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana (G.F.
  • Butnaru I; Eli Lilly and Company Ltd, Neuroscience, Bracknell, United Kingdom (F.M., O.G., E.F., H.S., Fr.P., T.M., S.B., E.S.); UK Dementia Research Institute at UCL, University College London, London, United Kingdom (I.B., G.S.); Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana (G.F.
  • Grubisha O; Eli Lilly and Company Ltd, Neuroscience, Bracknell, United Kingdom (F.M., O.G., E.F., H.S., Fr.P., T.M., S.B., E.S.); UK Dementia Research Institute at UCL, University College London, London, United Kingdom (I.B., G.S.); Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana (G.F.
  • Ficulle E; Eli Lilly and Company Ltd, Neuroscience, Bracknell, United Kingdom (F.M., O.G., E.F., H.S., Fr.P., T.M., S.B., E.S.); UK Dementia Research Institute at UCL, University College London, London, United Kingdom (I.B., G.S.); Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana (G.F.
  • Sanger H; Eli Lilly and Company Ltd, Neuroscience, Bracknell, United Kingdom (F.M., O.G., E.F., H.S., Fr.P., T.M., S.B., E.S.); UK Dementia Research Institute at UCL, University College London, London, United Kingdom (I.B., G.S.); Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana (G.F.
  • Fitzgerald G; Eli Lilly and Company Ltd, Neuroscience, Bracknell, United Kingdom (F.M., O.G., E.F., H.S., Fr.P., T.M., S.B., E.S.); UK Dementia Research Institute at UCL, University College London, London, United Kingdom (I.B., G.S.); Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana (G.F.
  • Pan F; Eli Lilly and Company Ltd, Neuroscience, Bracknell, United Kingdom (F.M., O.G., E.F., H.S., Fr.P., T.M., S.B., E.S.); UK Dementia Research Institute at UCL, University College London, London, United Kingdom (I.B., G.S.); Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana (G.F.
  • Pasqui F; Eli Lilly and Company Ltd, Neuroscience, Bracknell, United Kingdom (F.M., O.G., E.F., H.S., Fr.P., T.M., S.B., E.S.); UK Dementia Research Institute at UCL, University College London, London, United Kingdom (I.B., G.S.); Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana (G.F.
  • Murray T; Eli Lilly and Company Ltd, Neuroscience, Bracknell, United Kingdom (F.M., O.G., E.F., H.S., Fr.P., T.M., S.B., E.S.); UK Dementia Research Institute at UCL, University College London, London, United Kingdom (I.B., G.S.); Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana (G.F.
  • Monn J; Eli Lilly and Company Ltd, Neuroscience, Bracknell, United Kingdom (F.M., O.G., E.F., H.S., Fr.P., T.M., S.B., E.S.); UK Dementia Research Institute at UCL, University College London, London, United Kingdom (I.B., G.S.); Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana (G.F.
  • Li X; Eli Lilly and Company Ltd, Neuroscience, Bracknell, United Kingdom (F.M., O.G., E.F., H.S., Fr.P., T.M., S.B., E.S.); UK Dementia Research Institute at UCL, University College London, London, United Kingdom (I.B., G.S.); Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana (G.F.
  • Hutton M; Eli Lilly and Company Ltd, Neuroscience, Bracknell, United Kingdom (F.M., O.G., E.F., H.S., Fr.P., T.M., S.B., E.S.); UK Dementia Research Institute at UCL, University College London, London, United Kingdom (I.B., G.S.); Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana (G.F.
  • Bose S; Eli Lilly and Company Ltd, Neuroscience, Bracknell, United Kingdom (F.M., O.G., E.F., H.S., Fr.P., T.M., S.B., E.S.); UK Dementia Research Institute at UCL, University College London, London, United Kingdom (I.B., G.S.); Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana (G.F.
  • Schiavo G; Eli Lilly and Company Ltd, Neuroscience, Bracknell, United Kingdom (F.M., O.G., E.F., H.S., Fr.P., T.M., S.B., E.S.); UK Dementia Research Institute at UCL, University College London, London, United Kingdom (I.B., G.S.); Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana (G.F.
  • Sher E; Eli Lilly and Company Ltd, Neuroscience, Bracknell, United Kingdom (F.M., O.G., E.F., H.S., Fr.P., T.M., S.B., E.S.); UK Dementia Research Institute at UCL, University College London, London, United Kingdom (I.B., G.S.); Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana (G.F.
J Pharmacol Exp Ther ; 383(2): 117-128, 2022 11.
Article in En | MEDLINE | ID: mdl-36116796
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tau Proteins / Receptors, Metabotropic Glutamate / Alzheimer Disease Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: J Pharmacol Exp Ther Year: 2022 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tau Proteins / Receptors, Metabotropic Glutamate / Alzheimer Disease Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: J Pharmacol Exp Ther Year: 2022 Document type: Article Country of publication: